We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 104

FTC v. Phoebe Putney Health System, Inc., et al.
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • February 20 2013

On February 19, 2013, the United States Supreme Court in Federal Trade Commission v. Phoebe Putney Health System, Inc., et al., unanimously rejected


Preventive care court decision
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • November 19 2012

A federal judge in the District of Columbia circuit issued a stay from the contraceptive coverage mandate


Clarity on Doctrine of Equivalents Analysis for Chemical Claims
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • May 23 2017

On May 19, 2017, the Federal Circuit addressed and modified a rare grant of a preliminary injunction based on the doctrine of equivalents. In doing so


Dueling court cases issued on same day
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • July 24 2014

On Tuesday morning the U.S. Court of Appeals for the District of Columbia Circuit ruled that an IRS rule for a key piece of the 2010 Affordable Care


Supreme Court decision to drop on Thursday
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 25 2012

This morning the Supreme Court issued its ruling on the constitutionally of Arizona’s new immigration law


FTC v. Actavis
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • June 21 2013

On June 17, 2013, the Supreme Court issued an opinion authored by Justice Breyer in FTC v. Actavis, holding that "reverse payment" settlements are


ERISA preemption on the run San Francisco's health ordinance
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • January 23 2008

This month the ability of employers to rely on ERISA preemption to implement a uniform health program was again called into question


Medical syringe company finds competitors’ mark a sticking point; pricks its ire
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • August 21 2012

In DuoProSS Meditech Corp. v. Inviro Medical Devices, Ltd., No 2012-1050, 2012 WL 3292920 (Fed. Cir. Aug. 14, 2012), the U.S. Court of Appeals for the Federal Circuit ruled that the Trademark Trial and Appeal Board erred in failing to cancel two trademark registrations for medical syringes designed to be broken so they could not be reused


Separate written description? Oral arguments in en banc rehearing of Ariad v. Lilly
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • December 8 2009

The U.S. Court of Appeals for the Federal Circuit heard oral arguments on December 7 in its en banc rehearing of Ariad Pharmaceuticals Inc. v. Eli Lilly & Co., Fed. Cir., No. 2008-1248


Method of treatment claims alive and well
  • Kilpatrick Townsend & Stockton LLP
  • USA
  • December 20 2010

On December 17, 2010, the Federal Circuit issued its decision in Prometheus v. Mayo sustaining the patentability of Prometheus’s medical treatment claims